On July 24, President Trumped signed a series of executive order (EOs) focused on reducing Medicare beneficiary and program spending on prescription drugs. One executive order, the details of which were not immediately released, would set prices for drugs in Medicare Part B to no more than the prices paid by a basket of other […]
The German Pharmaceutical Model: Could it Work in the U.S.?
As drug prices continue to rise, policymakers debate drug pricing reform. The United States spends more on prescription drugs per capita than any other developed country. For example, Germany spends an average of $685 on retail prescription drugs per capita, while the United States spends over $1,000. Yet, Germany has a similar health care system […]
NCHC Statement on CARES 2.0 Act
Yesterday, negotiations over a fourth major COVID-19 relief package began in earnest after the Senate released the Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. The National Coalition on Health Care (NCHC) applauds some elements of the bill, including critical funding for schools and nursing homes, which is necessary for both our economic recovery […]
NCHC Statement on the Trump Administration’s Executive Orders
The National Coalition on Health Care (NCHC) strongly opposes theAdministration’s approach to address drug pricing through the executive orders released today. The executive orders rightly recognize the urgency of addressing drug prices, but we encourage the White House to pursue more comprehensive options proposed by the House and Senate. “Specialty and many branded drugs have […]
National Coalition on Health Care Issues Statement on the President’s FY2021 Budget Proposal
The President’s proposal, while only a framework for Congress’ consideration, establishes the priorities of the Administration. NCHC is concerned that the priorities of the Administration do not serve public health and do not align with the mission of the Coalition. […]
- 1
- 2
- 3
- …
- 30
- Next Page »